✦ LIBER ✦
Antifibrotic effect after low-dose imatinib mesylate treatment in patients with nephrogenic systemic fibrosis: an open-label non-randomized, uncontrolled clinical trial
✍ Scribed by T.R. Elmholdt; N.H. Buus; M. Ramsing; A.B. Olesen
- Book ID
- 111098966
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 276 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0926-9959
No coin nor oath required. For personal study only.